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Introduction 
Metabolic syndrome such as obesity and diabetes mellitus 
has recently increased, and low carbohydrate diets (LCD) 
have been noted in the medical and health field. Bernstein, 
Atkins and others have developed LCD 1, 2), and LCD has 
been widespread.
By the treatment of LCD, fat and fatty acid in the 
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Abstract
Background: Low carbohydrate diets (LCD) have been recently prevalent in the medical and health field, especially in 
diabetes mellitus. We have applied LCD on thousands of patients with metabolic diseases and reported the clinical effect of 
LCD so far. Through our experience and research concerning LCD, the physiological role of glucose and ketone bodies during 
the pre- and post-partum period was investigated in this study.  
Subjects and methods: Subjects were 60 normal pregnant woman who had a normal delivery in full-term, without an 
abnormal glucose intolerance. Methods included the measurement of the value of ketone bodies in the umbilical cord 
blood, placental tissue fluid and maternal blood, associated with the value of blood glucose. As ketone bodies, the value of 
3-hydroxybutyric acid (3-OHBA, beta-hydroxybutyric acid) was measured. 3-OHBA and glucose values were measured by 
the electrode method using Precision Exceed Kit (Abbott) and the conventional enzymatic cycling method, with comparison 
investigation of the data from two kits. 
Results: The average 3-OHBA levels were as follows: 2,235.0 μmol/L in the placenta, 779.2 μmol/L in the umbilical cord 
blood, in which the former is significantly higher than the latter (p < 0.001), 240.4μmol/L in the newborn after four days, 
and 366.7μmol/L after 30 days. The standard 3-OHBA level in a healthy man is less than 85 μmol/L. Glucose levels in the 
umbilical cord and placenta were 78.6 mg/dL vs 74.9 mg/dL, with no significant difference, and was the same as that of the 
pregnant woman. Accuracy management of the two kits revealed a significant correlation ( r = 0.94,  p < 0.001). 3-OHBA 
values of the maternal blood and umbilical cord blood were extremely elevated from the standard level, with a mutual 
significant correlation (r = 0.724,  p < 0.001, n = 416).
Conclusion: This clinical study concerning ketone bodies during pre- and post-partum period was investigated, and 
revealed that 1) a clinically rapid useful kit for ketone bodies had high reliability and validity compared with conventional 
kit, 2) elevated values of 3-OHBA were shown in the placental tissue fluid, umbilical cord, newborn and maternal blood, 3) 
3-OHBA would be a physiologically indispensable element in nutrition metabolism for fetus and newborn at least until 30 
days, with further development of investigation for ketone bodies.
Ketone body elevation in placenta, umbilical cord, 
newborn and mother in normal delivery
body tends to burn for a long time. It causes elevated blood 
ketone bodies, which have sometimes been regarded as 
high riskfactors, because of insufficient correct differential 
diagnosis of hyperketonemia whether it is ketoacidosis or 
ketosis. 
As a matter of fact, ketone diets were applied to infants
with epilepsy for a long time, associated with hyperketonemia
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Table 1. 3-OHBA and glucose values in the umbilical cord, placenta, and newborn.
Range Average n KitMedian
Values of 3-OHBA are measured by a) Precision Exceed, Abbott and b) the conventional enzyme cycling method kit. c) Glucose values are simultaneouly
measured by the same kit as a). 3-OHBA: 3-hydroxybutyric acid, beta-hydroxybutyric acid.
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and without any complications. This treatment has been 
recommended by international guidelines such as Cochrane 
Library and National Institute for Health and Care Excellence
(NICE) 3 - 5 ) .
As for LCD and research of ketone bodies, we have 
continued LCD movement for more than 12 years. Ebe K. 
first started in Japan in 1999 with lots of books, and Bando 
H. developed this movement with medical presentations 6 - 9).
After that, Ebe K. established the Japan carbohydrate 
restriction clinical promotion association, and Muneta T has 
broadened activity in OB/GYN and pediatrics fields 10, 11). 
Our study has come to the next stage. Firstly we could 
measure the value of ketone bodies from the umbilical cord,
and from the placenta tissue fluid, in which the validity of the
measurement was investigated and clarified. Furthermore, 
the value of ketone bodies in maternal blood, placenta, 
umbilical cord, and newborn system was firstly investigated 
and argued in this report. 
Subjects and methods
Subjects were 60 normal pregnant women who had 
a normal delivery in full-term, without any abnormal 
glucose tolerance or gestational diabetes mellitus. As ketone 
bodies, the value of 3-hydroxybutylic acid (3-OHBA, beta-
hydroxybutylic acid) was measured. Methods included the 
measurement of the values of 3-OHBA in umbilical cord 
blood, placental tissue fluid and maternal blood, associated 
with the value of blood glucose.
The measurement of 3-OHBA and glucose was performed
from the placental tissue fluid obtaining by slow and soft 
pressure for placenta without circulating blood. We used the
Precision Exceed Kit ( No. 44562003, registration 22300
AMX00567000; Abbott Japan, Kashiwa, Chiba, Japan) for 
measurement of 3-OHBA. The standard value of 3-OHBA 
in the blood of a healthy man is less than 85 μmol/L, and 
its measurement range is 30 to 8,000 μmol/L. The detail of 
this kit can be obtained in the HP of Abbott Co., Inc. 12, 13). 
The data of 3-OHBA obtained from the Precision 
Exceed Kit was compared with those from the conventional 
enzymatic cycling method at usual professional laboratories, 
and the validity of Precision Exceed Kit was investigated. 
Furthermore, we had 4 types of specimen including the 
umbilical blood, placental tissue fluid, mother blood and 
newborn blood, and 2 measure kit for 3-OHBA which are 
Precision Abbott and conventional enzyme cycling method. 
The summarized protocol is shown in Table 1.
Ketone bodies include three chemicals, 1) acetoacetate 
(AcAc), the source of the two other ketone bodies, if 
not oxidized to form usable energy, 2) acetone, not an 
energy source, but instead exhaled or excreted as waste, 3) 
3-hydroxybutyric acid (3-OHBA, beta-hydroxybutyric acid), 
not technically a ketone, but reversibly produced from AcAc, 
with useful energy 14, 15). In this study, we have measured 
3-OHBA levels as ketone bodies.
Statistical analyses
Data were shown as the mean ± standard deviation. For 
statistical analyses, correlation coefficients were calculated 
according to the Mann-Whitney U test in the comparison of 
two groups. We used two apparatuses for statistical analyses, 
which were the JMP (Version 8) statistical analysis software 
(JMP Japan Division of SAS Institute Japan Ltd., Minato-
ku, Tokyo, Japan) and the Microsoft Excel analytical tool. 
p < 0.001
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Ethical considerations
The present study was conducted in compliance with 
the ethical principles of the Declaration of Helsinki (Note of 
Clarification added at the 2004 World Medical Association
General Assembly in Tokyo) and Japan’s Act on the Protection
of Personal Information, and with reference to the Ministerial
Ordinance on Good Clinical Practice (GCP) for Drugs 
(Ordinance of Ministry of Health and Welfare No.28 of March
27, 1997) and the Ethical Guidelines for Epidemiological 
Research established by Japan’s Ministry of Health, 
Labour and Welfare, and Ministry of Education, Culture, 
Sports, Science and Technology. The present study was 
conducted after examination and approval for the ethics and 
appropriateness of the study at a meeting of the Muneta 
OB/GYN Clinic Ethics Committee for Scientific Research 
Involving Human Subjects, including several experts 
(Approval number #105-2).
Results
1) The 3-OHBA value in the umbilical cord, placenta and 
newborn, with glucose value shown in Table 1. The 3-OHBA 
level in the placental tissue fluid was 2,235.0 μmol/L on 
average, and was 779.2 μmol/L in the umbilical cord blood; 
the former was significantly higher than the latter (p < 0.001).
Fig. 1. 3-OHBA values in the umbilical cord and placenta 
tissue.
Results are expressed as mean ± standard deviation (n = 60 
each). The mean 3-OHBA value in the placental tissue is 
significantly higher than that in the umbilical cord by the 
Mann-Whitney U test (p < 0.001). 3-OHBA: 3-hydroxybutyric 
acid, beta-hydroxybutyric acid.
Fig. 2. Glucose level in the umbilical cord and placenta 
tissue.
Results are expressed as mean ± standard deviation (umbilical 
cord, n = 55; placenta, n = 57). Neither level has any significant 
difference by the Mann-Whitney U test. n.s.: not significant.
The 3-OHBA value in the newborn (4 days and 30 days) was 
much higher than the standard level. Furthermore, glucose 
level in umbilical cord and placenta was almost the same 
with no significant difference.
2) The 3-OHBA value in placental tissue fluid was 
significantly higher than that of the umbilical cord (p < 0.001,
Fig. 1). The former was revealed to be about three times 
higher than the latter, and was 20 ~ 30 fold higher than the 
standard blood level (less than 85 μmol/L).
3) The glucose level in the placental tissue fluid was 75 ~ 
80 mg/dL, which was not significantly different than the 
umbilical cord of all pregnant woman (Fig. 2).
4) Accuracy management of 3-OHBA by precision exceed 
was investigated. Figure 3 showed the correlation of 3-
OHBA data by two measurements via the electrode method 
(Precision Exceed, Abbott) and the enzymatic cycling method
(conventional kit in professional laboratory), with significant 
correlation (p < 0.001). 
5) The 3-OHBA values of maternal blood and umbilical cord
blood are shown in Fig. 4, with significant correlation (p < 
0.001, n = 416). These data were from the enzymatic cycling 
method, which has been used as the standard method in 
usual professional laboratories.
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Fig. 3. Accuracy management of 3-OHBA by precision exceed.
Correlation of 3-OHBA data between two measurements, electrode and enzymatic cycling 
methods are shown. Significant correlation is observed (r =  0.94, p < 0.001, n = 31). 
3-OHBA: 3-hydroxybutyric acid, beta-hydroxybutyric acid.
Fig. 4. 3-OHBA values in the maternal and umbilical cord.
Maternal and umbilical cord values of 3-OHBA are measured by enzymatic cycling method, in which a significant 
correlation is observed (r = 0.724, p < 0.001, n = 416). 3-OHBA: 3-hydroxybutyric acid, beta-hydroxybutyric acid.
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Discussion
1) Low carbohydrate diet (LCD)   
According to a Dietary Intervention Randomized 
Controlled Trial (DIRECT) study in Europe, LCD without 
calorie restriction (CR) was compared to a Mediterranean 
diet with CR and fat restriction with CR, in which LCD showed
the predominance effect 16, 17). In Japan, the coauthors have
vigorously treated thousands of patients with obesity, metabolic
syndrome and other diseases 6- 11). Further development would
be expected through Japan’s low carbohydrate restriction 
clinical promotion association in the future 18). As LCD has 
become more popular, the correct understanding concerning 
hyperketonemia and differential diagnosis of ketosis and 
ketoacidosis become more widely spread.
 
2) Ketone bodies   
From an evolutionary perspective, ketosis has been 
considered the physiological response to fasting in Homo 
sapiens 19-21). 
Ketone bodies and glucose metabolism, we can consider
for vertebrae evolution 22). The eggs of oviparous animals,
such as amphibian and birds species, contain no carbohydrates,
but have fat and protein, which can feed and grow up to 
embryo. This evolution was transmitted to mammal species. 
At first, a fertilized egg was implanted, and after that, huge 
nucleated red blood cells have been seen, during yolk sac 
hematopoiesis. This phenomenon indicates that metabolism 
may be possible without carbohydrates.
Recently, the physiological role of ketone bodies has 
been clarified, including various beneficial functions 20, 23). 
Ketone bodies have provided non-glucose substrate to the 
hypertrophied brain, sparing muscles from destruction for 
glucose synthesis. It has a protective role for epileptogenesis 
by preventing both after-discharge generation and propagation
in kindling seizures 24, 25) . Furthermore, it has a protective 
role for nerve cells and neurons, and a prophylaxis effect 
for Alzheimer’sand Parkinson’s disease 25-28). Thus, ketone 
bodies may aggressively become a protective energy source 
for brain in several reports 14, 15).
3) Clinical application   
 This study has spread the clinical application for the 
measurement of ketone bodies. 
Data obtained from the Electrode method (Fig. 3) 
revealed extremely high significant correlation with those 
by enzyme cycling method (p < 0.001), suggesting its rapid 
usefulness in clinical setting. 
Before this report, we came to know that Abbott Co., 
Ltd. had no experience or no data to measure the serum or 
plasma of a newborn. Therefore this is the first report of the 
level of 3-OHBA in the blood of newborns at 4 and 30 days 
by rapid procedure using a small amount of blood, as well as 
in the placenta, umbilical cord and mother. 
Accuracy management was successful, as a highly 
significant coefficient was found (r = 0.97) with reliability 
and validity. The standard value of 3-OHBA in the blood 
for a normal healthy man is less than 80 μmol/L, and the 
measurement range is 30 ~ 8,000 μmol/L 12, 13). Using these 
kits, further data and speculation would be expected in 
future investigation. For clinical application of this kit, 
pregnant women with nausea and vomiting in emergency 
treatment were utilized, with successful rapid and adequate 
diagnosis 29). 
Historically speaking, the measurement of 3-OHBA 
in blood had been used for the management of diabetic 
ketoacidosis, and after that rapid enzymatic methods were 
developed 30, 31) . The first of these systems is marketed by 
GDS Dianostics (Elkart, IN, USA), which needs only 2 min 
to work, with dilution of serum at a specific temperature. 
A second generation system was introduced by Abbott 
Laboratories (Bedford, MA, USA). The Precision XtraTM 
needs a finger stick blood specimen (5 μL) within 30 seconds,
and is accurate for 3-OHBA from 30 ~ 8,000 μmol/L 32).
These environments allowed users to obtain 3-OHBA 
and glucose values immediately in clinical settings. That is 
why we could investigate and summarize this report.  
4) Data Analysis  
The authors have begun to develop LCD for patients 
including pregnant women, infants and newborns, with 
continuous research of glucose and ketone bodies. Based on
several previous investigations on LCD and ketone bodies 11, 12),
 we summarized this study. This is the first report to clarify 
the physiological metabolism of glucose and ketone bodies 
in the placenta, umbilical cord, mother and newborn.
Firstly, Table 1 and Fig. 1 showed that the ketone bodies’
value was extremely high in the placental tissue fluid, 
approximately 20 ~ 30 fold higher than the standard level 
(85 μmol/L), and three times that of the umbilical cord. By
contrast, the glucose values in the umbilical cord and placenta
were almost the same with no significant difference, and the 
glucose levels were same as that of a healthy man (Fig. 2). 
These results would suggest that nutrition metabolism in a 
fetus may depend on the fatty acid metabolism.  
Successively, the 3-OHBA value in a newborn at 30 days
was still high (366.7 μmol/L in average, Table 1), suggesting 
that ketone bodies may be involved in the energy production 
for the growth process of a newborn until at least one month.
Future investigation on nutrition balance (glucose, protein, 
lipid), glucose intake amount, element of breast milk or 
artificial milk and energy in/out would be necessary to 
further clarify.
5) Newborn and ketone bodies   
3-OHBA data (n = 416) of a mother and umbilical cord
on delivery were measured by conventional enzymatic cycling
method (Fig. 4 ), with mutual significant correlation. When 
we observe 3-OHBA values in the mother blood, about 70% 
of them were elevated from the standard level (85 μmol/L).
The average values of ketone bodies were 2,235 μmol/
L in the placenta, 779.2 μmol/L in the umbilical cord, 366.7 
μmol/L in a newborn of 30 days, 240.4 μmol/L in a newborn 
of 4 days, and less than 85 μmol/L in normal adults (Table 1).
Elevated 3-OHBA in the newborn would suggest that newborns
may start producing ketone bodies in the liver, formerly 
given from the placenta.
Furthermore, two more factors would be involved in the 
growth of newborns, which are preparation for starvation 
after delivery due to rapid growth of fat tissue of the fetus in 
the third trimester, and the high amount of fat in breast milk 
supporting lipid metabolism.
Our results are compatible with the report of Akram M 
et al. 33) for elevated ketone bodies in newborns and mothers. 
There is some possibility and speculation concerning the 
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metabolism of newborns. Fukao T et al. reported that the 
FFA/total ketone body ratio is useful for evaluation of ketone
body metabolism and that defects in ketogenesis include 
mitochondrial hydroxymethylglutaryl-coenzyme A (HMG-
CoA) synthase (mHS) deficiency and HMG-CoA lyase (HL) 
deficiency 34). 
Newborns from the high glucose mother group revealed
higher 3-OHBA ( p = 0.040), lactate ( p = 0.040), and 
triglyceride ( p < 0.001), suggesting that pregnancy state 
would influence the metabolism of carbohydrate, lipids 
and the degradation pathways of amino acids, inducing 
to metabolism transportation from the mother across the 
placenta 35).
Moreover, lactate may become the focus of lipid 
and glucose metabolism in the future. Babies which were 
≥ 35 weeks, ≤ 48 hours old and at risk of hypoglycemia, 
were investigated by measurement of plasma glucose, 
β-hydroxybutyrate, lactate and insulin concentrations 36).
Glucose and β-hydroxybutyrate levels were low, but 
lactate level varied widely. Infants of diabetics had lower 
β-hydroxybutyrate and higher insulin concentrations. These
findings suggest that lactate, rather than ketones, may provide
alternative cerebral fuel in hypoglycemic newborns 36). Platt 
MW et al. also stated the paradigm shift for metabolism of 
newborn brains into lactate instead of glucose 37).
6) Pregnancy and ketone bodies   
We cannot find previous reports for the relationship of 
ketone bodies values in the umbilical cord and mother on 
delivery with a large sample size (Fig. 4). Furthermore, these 
data were from the conventional professional laboratory with 
high validity. As a result, elevated 3-OHBA levels in the 
umbilical cord and maternal blood with mutual correlation 
were observed for the first time in this study.
Maternal 3-OHBA value had significant correlation 
with that of the umbilical cord, and showed about half level 
(Fig. 4). Influencing factors are considered to be as follows: 
1) the transition of ketone bodies from placenta to maternal 
blood vessel, 2) the ratio of the transition and gradient, 3) 
metabolism difference between newborn and mother, 4) 
carbohydrate intake of mother in a few days of delivery, and 
dehydration, 5) relationship with hyperlipidemia in third 
trimester , 6) fetus environment and metabolism concerning 
ketone bodies, fat and glucose. 
Metabolite profiles of arterial and venous umbilical cord
plasma and maternal plasma were obtained by 1H nuclear 
magnetic resonance (NMR) spectroscopy 38). As for 3-OHBA 
concentration, mother vs umbilical cord plasma showed 2.87 
vs 0.91 μmol/L in normo-ponderal full-term (FT) delivery, 
and 1.06 vs 0.57 μmol/L in very-low-birth-weight (VLBW) 
delivery.
These data seem to be consistent with our results for 
concentration and ratio from mother and umbilical cord. The
measured number was 8 in Tea I et al. 38) and 416 in our study,
indicating that our data would become the fundamental 
comparison of 3-OHBA between mother and umbilical cord 
(Fig. 4). 
The placenta has been known to transaminate amino 
acids such as leucine, isoleucine and valine to their 
respective alpha-ketoacids, which are released into the 
umbilical and uterine circulation and contribute to placental 
ammonia production, consistent with the high level of beta-
hydroxybutyrate in maternal plasma. Further evaluation 
would be expected with our fundamental data of this study.
7) Fetus and ketone bodies   
There have been some reports concerning ketone bodies 
and fetuses/newborns. 
Firstly, Rizzo T et al. 39) reported that elevated 3-OHBA 
during pregnancy attenuated intelligence quotient after 
several years. This is one of the causes for the prevalent 
misunderstanding that elevated ketone bodies would be 
risky in clinical settings. 
This report, however, has several questionable points, 
such as: 1) slightly elevated level of 3-OHBA of 100 ~ 180
μmol/L, 2) probable unstable blood glucose profile, 3) possible
elevated postprandial glucose and mean amplitude of glycemic
excursions (MAGE), 4) existing oxidative stress risk associated
with factors 1)-3) influencing intelligence quotient. 
On the other hand, our research has clarified the following:
1) in Pregnant women with morning sickness have ketone 
body levels more than 3,000 μmol/L, 2) placental tissue fluid
always contains ketone bodies no lower than 2,000 μmol/L,
3) newborns from 4 to 30 days have elevated 3-OHBA, 
approximately 240 ~ 367 μmol/L. From these data, the 
decreased intelligence quotient due to hyperketonemia found 
by Rizzo’s 39) seems to have no relation to ketone bodies.
Consequently, LCD often induces elevated ketone body
levels, but it is not risky in light of the intrauterine environment
of a fetus. Currently, ketone bodies can produce energy 
efficiently in the environment without enough oxygen, and 
give positive effects on cranial nerves 26). Ketone bodies in 
the placenta were proved to exist in such high concentration 
physiologically, indicating that ketone bodies may be 
not risky, nor lower the intelligence quotient nor have 
teratogenicity.
Secondly, pregnant mice were investigated by being 
given two types of food: an ordinary diet (9.3 ~ 15.5 kcal/
day, fat 5%, carbohydrate 76.1%, protein 18.9%) and a 
ketogenic diet (20.1 ~ 33.5 kcal/day, fat 67.4%, carbohydrate 
0.5%, protein 15.3%) 40, 41).
However, this report seemed to have a fundamental 
problem in research design. Muridae species such as mouse 
and rat originally eats seeds of grass that are equal to cereal
or low fat food. Animal experimentation with food is completely
different from study in medicine giving oral or venous 
administration. Everyone knows the famous and incorrect 
medical report of about 100 years ago wherein an experiment
of giving high fat food to rabbits caused extreme arterosclerosis
in the carotid artery, which was of a similarly incorrect design.
Therefore, the results of Sussman 40, 41) would be difficult to 
apply to that of human.
Furthermore, special food for humans with only 0.5% 
of carbohydrate cannot be prepared or made in ordinary 
situations.
Thirdly, Japan Society of Obstetrics and Gynecology has
been responsible for the diagnosis and treatment of pregnant 
women in Japan. In relation to this association, Japan 
Gynecologist Association press conference was held in 
February, 2016, with the comment “Pregnancy and nutrition 
– Do not deliver small babies, nor grow them too big –” 42). 
Their presentation included a series of medical study on mice
experiment by Sussuman 40, 41). However, this seemed not to be
appropriate educational content for ordinary expecting women.
The desirable slogan should include adequate knowledge 
and advice about nutrition.
In contrast, there is a reliable medical review concerning 
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pregnancy and diabetes 43). The influence of gestational 
diabetes mellitus was investigated by meta-analysis of twelve
studies involving 6,140 infants. The results were that infants 
aged 1~2 years from diabetic mothers had significantly lower 
scores of mental and psychomotor development compared to 
control infants. Consequently, we should consider not ketone 
bodies, but glucose and glycative changes from now on.
8) Limitation and future of study   
Previous reports for the relationship of ketone body 
values in the umbilical cord and mother on delivery have not 
included so great a sample size, indicating our data would 
become the fundamental and useful report in this field. 
From the axis of mother – placenta – umbilical cord 
– fetus, concentration of gradient and movement of ketone 
bodies would be considered. Value of 3-OHBA in the placenta
is extremely elevated, about three times that of the umbilical 
cord, and maternal value is half that of the umbilical cord. 
These data would indicate that the placenta may produce 
ketone bodies and supply its energy to the fetus. On contrast, 
even if maternal ketone bodies might move to placental tissue,
the influence is subtle because of 1/6 of 3-OHBA level in 
matenal blood compared to the placenta.
Consequently, we speculate that the limitation of this
study would be a lack of data from fetuses, so we have planned
to investigate the fetus in detail.
Another major problem seems to be glucose and glycative
influence 20, 21). The prevalence of gestational diabetes mellitus
(GDM) seems to be 12.08% in Japan according to the 
guideline 44), and the ratio of pregnant women with obesity 
and/or metabolic syndrome would be around 8%. Then, in 
our OB/GYN clinic, about 20% of subjects would probably 
be advised to be on LCD treatment, and others would have 
no particular health problems. 
Our results showed that elevated 3-OHBA was seen in
70% of subjects. Associated with statistical data, probably
50 ~ 60% of the pregnant mothers without any complications
may show elevated 3-OHBA. Therefore, we plan to investigate
the difference between diabetic and non-diabetic groups in 
future research. 
Conclusion 
We investigated clinical study concerning ketone bodies 
during pre- and post-partum period, and concluded that 
1) a clinically rapid useful kit for ketone bodies had high 
reliability and validity compared with conventional kits, 2) 
the elevated values of 3-OHBA were shown in the placental 
tissue fluid, umbilical cord, newborn and maternal blood, 3) 
3-OHBA would be a physiologically indispensable element 
in nutrition metabolism for fetus and newborn at least until 
30 days, with further development of ketone body research.
Acknowledgement 
A summary version of this article was presented at 
the 17th and 18th Scientific Meeting of Japan Society of 
Metabolism and Clinical Nutrition in 2014 and 2015. 
Statement of conflict of interest
Non contributory.
References  
1) Bernstein RK. Dr. Bernstein’s Diabetes solution: The 
Complete Guide to Achieving Normal Blood Sugars. Little,
Brown US, New York, 2011.
2) Atkins RC. Dr Atkins’ New Diet Revolution. Harper-
Collins, New York, 2001.
3) Levy RG, Cooper PN, Giri P. Ketogenic diet and other 
dietary treatments for epilepsy. Cochrane Database Syst Rev.
2012; 3: CD001903. doi: 10.1002/14651858.CD001903.
pub2.
4) Martin K, Jackson CF, Levy RG, et al. Ketogenic and 
other dietary treatments for epilepsy. Cochrane Database 
Syst Rev. 2016; 2:CD001903. doi: 10.1002/14651858.
CD001903.pub3.
5) National Institute for Health and Care Excellence (NICE).
Epilepsies: Diagnosis and management. Clinical guideline.
2012 January 11. https://www.nice.org.uk/guidance/cg137/
resources/epilepsies-diagnos
6) Ebe K, Ebe Y, Yokota S, et al. Low Carbohydrate diet (LCD)
treated for three cases as diabetic diet therapy. Kyoto Medical
Association Journal. 2004; 51: 125-129. (in Japanese)
7) Ebe K. Better diabetes without staple food: Recommendation
 for low carbohydrate diet (LCD). Toyo Keizai Publishing 
Co. Ltd., Tokyo, 2005. (in Japanese)
8) Bando H, Nakamura T. Carbo-count therapy and low 
carbohydrate diet (LCD). The Journal of the Therapy. 
2008; 90: 3105-3111. (in Japanese).
9) Bando H, Ebe K, Nakamura T. New era of low carbohydrate
diet: Clinical efficacy with more than 2000 cases in Japan
for the treatment of metabolic syndrome. World Organization
of Family Doctors-19th Europe Conference, Lisbon, 2014. 
(abstract)
10) Muneta T, Kawaguchi E, Matsumoto M, et al. The effect 
of low carbohydrate diet (LCD) for gestational diabetes 
and its verification: Is hyperketonemia clinically due to 
LCD risky? (2nd report). The Journal of Metabolism and 
Clinical Nutrition. 2014; 17: S-203. (abstract in Japanese) 
11) Muneta T, Kawaguchi E, Nagai Y, et al. Investigation of
hyperketonemia in fetus, newborn and placenta: 3rd report
of gestational study associated with low carbohydrate diet
(LCD). The Journal of Metabolism and Clinical Nutrition. 
2015; 18: S-184. (abstract in Japanese)
_ 14 0 _
Ketone Bodies Elevation in Placenta, Umbilical Cord, Newborn and Mother
12) Abbott Japan. Instruction manual. Precision Xtra. 
ht tp://products.abbott.co.jp/medical /diabetes/pdf/
precision_xceed_h.pdf (in Japanese)
13) Abbott Co Ltd. Owner’s Guide. Precision Xtra.
https://www.abbottdiabetescare.com/precision-xtra#nogo
14) White H, Venkatesh B. Clinical review: Ketones and brain
injury. Crit Care. 2011; 15: 219-228. 
15) Murray RK, Granner DK, Mayes PA, et al. Harper’s 
Illustrated Biochemistry 29th Edition (LANGE Basic 
Science). McGraw-Hill Medical, 2012
16) Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with 
a low-carbohydrate, Mediterranean, or low-fat Diet. N 
Engl J Med. 2008; 359: 229-241. 
17) Schwarzfuchs D, Golan R, Shai I. Four-year follow-up 
after two-year dietary interventions. N Engl J Med. 2012; 
367: 1373-1374.
18) Ebe K (Dir). Bulletin of Japan Low Carbohydrate 
Restriction Clinical Promotion Association. 2013-2016; 
vol.1-5. (in Japanese) 
19) Sussman D, Germann J, Henkelman J. Gestational 
ketogenic diet programs brain structure and susceptibility 
to depression & anxiety in the adult mouse offspring. 
Brain Behav. 2015; 5(2): e00300. doi: 10.1002/brb3.300
20) Urich K (Au), King PJ (Trans). Comparative Animal 
Biochemistry. Springer-Verlag, Berlin, Heidelberg, 2013.
21) van Veen MR, van Hasselt PM, de Sain-van der Velden 
MG, et al. Metabolic profiles in children during fasting. 
Pediatrics. 2011;127(4):e1021-7. doi: 10.1542/peds.2010-
1706. Epub 2011 Mar 21. 
22) Veech RL, Chance B, Kashiwaya Y, et al. Ketone bodies, 
potential therapeutic uses. IUBMB Life. 2001; 51: 241-
247.
23) Veech RL. The therapeutic implications of ketone bodies: 
The effects of ketone bodies in pathological conditions: 
Ketosis, ketogenic diet, redox states, insulin resistance, 
and mitochondrial metabolism. Prostaglandins Leukot 
Essent Fatty Acids. 2004; 70: 309-319. 
24) Dahlin M, Mansson JE. Amark P. CSF levels of dopamine
and serotonin but not norepinephrine metabolites are 
influenced by the ketogenic diet in children with epilepsy. 
Epilepsy Res. 2012; 99: 132-138. 
25) Jiang Y, Yang Y, Wang S, et al. Ketogenic diet protects 
against epileptogenesis as well as neuronal loss in 
amygdaloid-kindling seizures. Neurosci. Lett. 2012; 508: 
22-26.
26) Henderson ST. Ketone bodies as a therapeutic for 
Alzheimer's disease. Neurotherapeutics. 2008; 5: 470-480. 
27) Hertz L, Chen Y, Waagepetersen HS. Effects of ketone 
bodies in Alzheimer's disease in relation to neural 
hypometabolism, β-amyloid toxicity, and astrocyte function.
J Neurochem. 2015; 134: 7-20. 
28) Van der Auwera I, Wera S, Van Leuven F, et al. A ketogenic
diet reduces amyloid beta 40 and 42 in a mouse model of 
Alzheimer's disease. Nutr Metab (Lond).2005; 2: 28.
29) Ferguson I, Mullins ME. Diagnostic accuracy of fingerstick
β-hydroxybutyrate for ketonuria in pregnant women with 
nausea and vomiting. Acad Emerg Med. 2013; 20: 954-956. 
30) Artuch R, Vilaseca MA, Farre C, et al. Determination of 
lactate, pyruvate, beta-hydroxybutyrate and acetoacetate 
with a centrifugal analyzer. Eur J Clin Chem Clin Biochem.
1995; 33: 529-533.
31) Porter WH, Yao HH, Karounos DG. Laboratory and clinical
evaluation of assays for beta-hydroxybutyrate. Am J Clin 
Pathol. 1997; 107: 353-358.
32) Laffel L. Ketone bodies: A review of physiology, 
pathophysiology and application of monitoring to 
diabetes. Diabetes Metab Res Rev. 1999; 15: 412-426.
33) Akram M. A focused review of the role of ketone bodies 
in health and disease. J Med Food. 2013; 16: 965-967. 
34) Fukao T, Mitchell G, Sass JO, et al. Ketone body 
metabolism and its defects. J Inherit Metab Dis. 2014; 37: 
541-551. 
35) Scholtens DM, Muehlbauer MJ, Daya NR, et al. 
Metabolomics reveals broad-scale metabolic perturbations
in hyperglycemic mothers during pregnancy. Diabetes Care.
2014; 37: 158-166.
36) Harris DL, Weston PJ, Harding JE. Lactate, rather than
ketones, may provide alternative cerebral fuel in 
hypoglycaemic newborns. Arch Dis Child Fetal Neonatal 
Ed. 2015; 100: F161-164. 
37) Platt MW. Lactate, glucose and the neonatal brain: it's 
time to challenge the paradigm. Arch Dis Child Fetal 
Neonatal Ed. 2015; 100: F96-97. 
38) Tea I, Le Gall G, Küster A, et al. 1H-NMR-based 
metabolic profiling of maternal and umbilical cord 
blood indicates altered materno-foetal nutrient exchange 
in preterm infants. PLoS One. 2012; 7(1): e29947. doi: 
10.1371/journal.pone.0029947. 
39) Rizzo T, Metzger BE, Burns WJ, et al. Correlations 
between antepartum maternal metabolism and intelligence
of offspring. N Engl J Med. 1991; 325: 911-916.
40) Sussman D, van Eede M, Wong MD, et al. Effects of a 
ketogenic diet during pregnancy on embryonic growth in 
the mouse. BMC Pregnancy Childbirth. 2013; 13: 109. 
doi: 10.1186/1471-2393-13-109. 
41) Sussman D, Ellegood J, Henkelman M. A gestational 
ketogenic diet alters maternal metabolic status and 
offspring physiological growth and brain structure in the 
neonatal mouse. BMC Pregnancy Childbirth. 2013; 13: 
198. doi: 10.1186/1471-2393-13-198.
42) Japan Association of Obstetricians and Gynecologists. 
Pregnancy and Nutrition: Do not deliver baby small, nor
grow big. The 95th Press Conference of Japan gynecologist 
Association, Feb 16, 2016, Tokyo. http://www. jaog.or.jp/
all/conference/ (in Japanese) 
43) Camprubi Robles M, Campoy C, Garcia Fernandez L, 
et al. Maternal diabetes and cognitive performance in 
the Offspring: A systematic review and meta-analysis. 
PLoS One. 2015; 10(11): e0142583. doi: 10.1371/journal.
pone.0142583. 
44) The Japan Diabetes Society. Evidence-based Practice 
Guideline for the Treatment for Diabetes in Japan 2013. 
http://www. jds.or. jp/modules/en/index.php?content_
id=44
